Prophylactic use of heparin for deep vein thrombosis in restrained psychiatric patients: a chart review

Gen Hosp Psychiatry. 2014 Nov-Dec;36(6):690-3. doi: 10.1016/j.genhosppsych.2014.06.007. Epub 2014 Jun 29.

Abstract

Objective: Physical restraint sometimes causes deep vein thrombosis (DVT) and pulmonary embolism. Although unfractionated heparin (UFH) is used for the prophylaxis of DVT, its effectiveness remained unknown for restrained patients.

Method: We conducted a chart review of restrained inpatients at Sakuragaoka Memorial Hospital in Japan. Restrained patients received subcutaneous injection of UFH 5000 IU bid from December 2008 to September 2010 [heparin (+) period] while UFH was not used from December 2010 to September 2012 [heparin (-) period]. A Doppler ultrasound scanning was performed to examine the presence of DVT. The incidence of DVT was compared between the two periods by chi-square test. A multiple logistic regression model was used to examine effects of demographic and clinical characteristics on the incidence of DVT.

Results: No significant difference was found in the incidence of DVT between the heparin (+) and (-) periods [11.8% (11/93) vs. 11.1% (13/117)]. Sedation [odds ratio (OR) = 3.78], physical comorbidities (OR = 6.29) and a longer duration of restraint (OR = 1.22) were associated with the incidence of DVT.

Conclusion: The use of UFH was not associated with any reduction in the incidence of DVT in restrained psychiatric patients.

Keywords: Deep vein thrombosis; Heparin; Pulmonary embolism; Restraint; Sedation.

MeSH terms

  • Adult
  • Anticoagulants / administration & dosage
  • Anticoagulants / pharmacology*
  • Comorbidity
  • Conscious Sedation / adverse effects
  • Female
  • Heparin / administration & dosage
  • Heparin / pharmacology*
  • Hospitals, Psychiatric
  • Humans
  • Inpatients
  • Male
  • Mental Disorders / epidemiology
  • Mental Disorders / therapy*
  • Middle Aged
  • Restraint, Physical / adverse effects*
  • Retrospective Studies
  • Time Factors
  • Treatment Outcome
  • Venous Thrombosis / drug therapy*
  • Venous Thrombosis / epidemiology
  • Venous Thrombosis / etiology*

Substances

  • Anticoagulants
  • Heparin